# Efficacy and Safety of Sodium Heparin (Eurofarma)

> **NCT00894829** · PHASE3 · COMPLETED · sponsor: **Azidus Brasil** · enrollment: 104 (actual)

## Conditions studied

- Cardiac Surgery

## Interventions

- **BIOLOGICAL:** heparin sodium - Eurofarma
- **BIOLOGICAL:** heparin sodium - APP

## Key facts

- **NCT ID:** NCT00894829
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2013-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00894829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00894829, "Efficacy and Safety of Sodium Heparin (Eurofarma)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00894829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*